| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/17/2003 | US20030133932 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/17/2003 | US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen. |
| 07/17/2003 | US20030133929 Draining blood from the animal, separating blood cells from plasma, contacting plasma with a solvent in which lipids are soluble, separating plasma to reintroduce it into the animal, separating dissolved lipids |
| 07/17/2003 | US20030133914 Method for suppressing immune system response to transplanted tissue or cells |
| 07/17/2003 | US20030133911 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 07/17/2003 | US20030133909 An isolated polynucleotide encodes a polypeptide which comprising amino acids able to glycosylation, vaccines as an antitumor agent for treating mammal |
| 07/17/2003 | CA2473226A1 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| 07/17/2003 | CA2472893A1 Cancer treatment |
| 07/17/2003 | CA2472383A1 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 07/17/2003 | CA2472282A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | CA2472154A1 Use of antibodies against the muc18 antigen |
| 07/17/2003 | CA2472151A1 Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound |
| 07/17/2003 | CA2472111A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | CA2471936A1 Methods for using anti-muc18 antibodies |
| 07/17/2003 | CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | CA2471849A1 Antibodies against the muc18 antigen |
| 07/17/2003 | CA2471840A1 Novel compositions and methods for cancer |
| 07/17/2003 | CA2471750A1 Polyphenol inhibition of nucleoside diphosphate kinase-b activity and cancer metastasis |
| 07/17/2003 | CA2471737A1 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
| 07/17/2003 | CA2471431A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors |
| 07/17/2003 | CA2468888A1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 07/17/2003 | CA2463798A1 Modulation of immunostimulatory propertiies of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 07/16/2003 | EP1327687A1 Methods of infection with hepatitis c virus |
| 07/16/2003 | EP1327451A1 Adjuvants for vaccines |
| 07/16/2003 | EP1327450A1 Oral vaccination |
| 07/16/2003 | EP1326990A2 Packaging of positive-strand rna virus replicon particles |
| 07/16/2003 | EP1326986A2 Regulation of human sphingosine kinase-like protein |
| 07/16/2003 | EP1326978A2 Hematopoietin receptors hpr1 and hpr2 |
| 07/16/2003 | EP1326971A2 Proteins and nucleic acids encoding same |
| 07/16/2003 | EP1326967A2 Novel aggrecanase molecules |
| 07/16/2003 | EP1326961A2 Compositions and methods for inducing specific cytolytic t cell responses |
| 07/16/2003 | EP1326960A2 Microbes having an attenuating mutation comprising a transcription terminator |
| 07/16/2003 | EP1326897A2 Humanized anti-lt-beta-r antibodies |
| 07/16/2003 | EP1326896A2 Human anti-cd40 antibodies |
| 07/16/2003 | EP1326894A2 Novel tumor-associated marker |
| 07/16/2003 | EP1326888A2 Novel compounds |
| 07/16/2003 | EP1326887A2 Polypeptide from haemophilus influenza |
| 07/16/2003 | EP1326886A2 Basb208 nucleotide and amino acid sequences from haemophilus influenzae |
| 07/16/2003 | EP1326885A2 Novel compounds |
| 07/16/2003 | EP1326883A1 Antisense peptides to human fc receptors and their uses |
| 07/16/2003 | EP1326645A1 Complexes for transferring nucleic acids into cells |
| 07/16/2003 | EP1326639A1 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 07/16/2003 | EP1326638A2 Vaccines |
| 07/16/2003 | EP1326637A2 Vaccine comprising heat stress proteins from herbaceous plants |
| 07/16/2003 | EP1326636A2 Vaccine composition |
| 07/16/2003 | EP1326635A2 Pharmaceutical composition for immunisation against aids |
| 07/16/2003 | EP1326634A1 Vaccine composition comprising an antigen and a peptide having adjuvant properties |
| 07/16/2003 | EP1326633A1 Composition comprising immunogenic microparticles |
| 07/16/2003 | EP1326629A2 Methods and compositions for promoting the maturation of monocytes |
| 07/16/2003 | EP1326627A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 07/16/2003 | EP1326626A2 Methods for treating rheumatoid arthritis using il-17 antagonists |
| 07/16/2003 | EP1326625A1 Immunogenic composition of hepatitis c and methods of use thereof |
| 07/16/2003 | EP1326589A2 Nanoparticles |
| 07/16/2003 | EP1025231B1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance |
| 07/16/2003 | EP1019510B1 Vaccines derived from porcine circoviruses |
| 07/16/2003 | EP0951475B1 Metastatic colorectal cancer vaccine |
| 07/16/2003 | EP0801658B1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/16/2003 | EP0789767B1 A method for producing purified papillomavirus proteins |
| 07/16/2003 | EP0759935B1 Recombinant papilloma virus l1 |
| 07/16/2003 | EP0743856B1 Antigen-based heteropolymers for treating autoimmune diseases |
| 07/16/2003 | EP0688365B1 Fertility regulation with transforming growth factor beta |
| 07/16/2003 | CN1430626A Sheep lice Bobicola ovis allergen treatment |
| 07/16/2003 | CN1430505A Microspheres for active embolization |
| 07/16/2003 | CN1430504A Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into biological environmentat from polymer matrix |
| 07/16/2003 | CN1429911A Slow virus carrier system, method of producing carrier and its application |
| 07/16/2003 | CN1429908A Gene modification sequence of gene recombination hepatitis virus surface antigen and its product |
| 07/16/2003 | CN1429907A Method of obtaining transgenic rape chloroplast plant for producing foot-and-mouth disease vaccine |
| 07/16/2003 | CN1429906A Method of obtaining transgenic mountain lettuce chloroplast plant for producing foot-and-mouth disease vaccine |
| 07/16/2003 | CN1429843A Gene reform immune globulin with low immunogenicity and its application |
| 07/16/2003 | CN1429836A Hepatitis C virus high change region 1 synthetic peptide and its use |
| 07/16/2003 | CN1429625A Medicine for treating chronic hepatitis B |
| 07/16/2003 | CN1429624A Lung cancer transgene vaccine and its preparation method |
| 07/16/2003 | CN1114619C Preparation method of liver cancer murine monoclone antibody of mouse hybridoma strain Hepama-1 secretory |
| 07/15/2003 | US6593463 Malarial merozite surface protein (MSP); modified nucleic acid sequence; AT content has been reduced by replacing codons with mammary gland preferred codons; useful in development of a vaccine against malaria |
| 07/15/2003 | US6593461 Isolated DNA of given nucleotide sequence which encodes an amino acid sequence; hybridization; use in diagnosing, preventing and treating gastrointestinal disorders |
| 07/15/2003 | US6593453 Activated peptides and conjugates |
| 07/15/2003 | US6593147 Detection of prefrential particles in humans; obtain fluid sample, incubate with antibody, detect formation of immunocomplex |
| 07/15/2003 | US6593134 Propagation of chicken infectious anemia virus; prepare nutrient broth, inoculate with cells infected with marek's disease, propagate, recover infected cells |
| 07/15/2003 | US6593114 Staphylococcus aureus polynucleotides and sequences |
| 07/15/2003 | US6593105 Vector comprising a nucleic acid insert; alteration of amino acids within the helix-1 region; inability to convert to a disease-associated form; use in prophylaxis/gene therapy for neurodegenerative diseases |
| 07/15/2003 | US6593087 Nucleic acid from a nematode or an arthropod pest, encoding a P-glycoprotein homolog which regulates resistance to a macrocyclic lactone |
| 07/15/2003 | US6593083 For the detection of antibodies in body fluids; contacting the sample with polypeptide or fusion protein; detecting the antibody-polypeptide complex |
| 07/15/2003 | US6592877 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/15/2003 | US6592876 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 07/15/2003 | US6592875 Borrelia burgdorferi antigen at subvaccine level to alleviate symptoms |
| 07/15/2003 | US6592874 Togavirus capsid particle that does not contain genomic or RNA vector replicon nucleic acids |
| 07/15/2003 | US6592873 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids |
| 07/15/2003 | US6592872 Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein |
| 07/15/2003 | US6592871 Partial sequences of the C-100-3 and env/core with C-regions |
| 07/15/2003 | US6592869 Stable compressed freeze dried antigen and dissolution aid |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |
| 07/15/2003 | US6592862 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/10/2003 | WO2003056332A1 Diagnostic for scleroderma |
| 07/10/2003 | WO2003056295A2 Enterococcal virulence factors |
| 07/10/2003 | WO2003056010A2 An antisense strategy to modulate estrogen receptor response (er. alpha. and/or er. beta.) |
| 07/10/2003 | WO2003056008A1 Regulation of the expression of bacterial motility-associated genes |
| 07/10/2003 | WO2003055994A1 Hxhv virus, nucleic material, peptide material and uses |
| 07/10/2003 | WO2003055988A1 An avian embryo particulate biomass for the production of virus antigens |